Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients

被引：10

作者：

Berretta, M.

Lleshi, A.

Di Benedetto, F.

Bearz, A.

Spina, M.

Tirelli, U. ^{[1
]}

机构：

[1] Natl Canc Inst, Ctr Riferimento Oncol, Div Med Oncol, Aviano, PN, Italy

[2] Univ Modena & Reggio Emilia, Liver & Multivisceral Transplant Ctr, Modena, Italy

来源：

ANNALS OF ONCOLOGY | 2006年 / 17卷 / 07期

关键词：

D O I：

10.1093/annonc/mdj140

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1176 / 1177

页数：2

共 5 条

[1] Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy [J].

Bonnet, F ;

Lewden, C ;

May, T ;

Heripret, L ;

Jougla, E ;

Bevilacqua, S ;

Costagliola, D ;

Salmon, D ;

Chêne, G ;

Morlat, P .

CANCER, 2004, 101 (02) :317-324

[2]

CEROSIMO RJ, 2005, ANN PHARMACOTHER, V39, P128

[3] Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group [J].

Jatoi, A ;

Murphy, BR ;

Foster, NR ;

Nikcevich, DA ;

Alberts, SR ;

Knost, JA ;

Fitch, TR ;

Rowland, KM .

ANNALS OF ONCOLOGY, 2006, 17 (01) :29-34

[4]

PATT YZ, 2003, CANCER, V101, P578

[5] Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome [J].

Puoti, M ;

Bruno, R ;

Soriano, V ;

Donato, F ;

Gaeta, GB ;

Quinzan, GP ;

Precone, D ;

Gelatti, U ;

Asensi, V ;

Vaccher, E .

AIDS, 2004, 18 (17) :2285-2293

← 1 →